Ortopedia e Traumatologia Rizzoli-Argenta, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
IIa Clinica Ortopedica e Traumatologica, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Biomed Res Int. 2022 Jun 30;2022:3248526. doi: 10.1155/2022/3248526. eCollection 2022.
The purpose of this study is to compare the functional and clinical outcomes, blood loss, complication rate, and hospital length of stay (LOS) of total hip replacement (THR) using a minimally invasive tissue-sparing posterior superior (TSPS) approach and the standard posterior approach.
This retrospective, observational, double-centered study included 38 patients undergoing hip replacement. The patents were divided into two groups: control group (19 patients), who underwent surgery with the standard posterior approach, and treatment group (19 patients), who received the same type of implant with ceramic-on-ceramic bearing via the TSPS approach. Hemoglobin level was assessed preoperatively, on first and second postoperative days, and on discharge day. Harris hip score and Western Ontario and McMaster Universities Arthritis Index were used to measure the clinical and functional outcomes. Hospital LOS and incidence of early and late complications were assessed in both groups. Postoperative anteroposterior pelvis X-ray was performed to assess the correct positioning of implants.
Better early clinical outcomes ( = 0.0155), lesser blood loss ( < 0.0001), and reduced hospital LOS ( < 0.0001) were observed in the TSPS group than in the control group. No major adverse effects occurred in both groups, and a satisfactory implant orientation was achieved in all patients.
The TSPS approach is a reliable minimally invasive procedure for THR as it allows an accurate orientation of the components and provides better early postoperative functional outcomes, faster recovery, significantly lower blood loss, and shorter hospital LOS than the standard posterior approach. However, further research is needed to confirm the promising results and cost-effectiveness of the TSPS approach in larger cohorts with a longer follow-up period.
本研究旨在比较微创保留组织的后上(TSPS)入路与标准后入路全髋关节置换术(THR)的功能和临床结果、失血量、并发症发生率和住院时间(LOS)。
这是一项回顾性、观察性、双中心研究,共纳入 38 例接受髋关节置换的患者。患者分为两组:对照组(19 例)采用标准后入路手术,治疗组(19 例)采用 TSPS 入路和陶瓷对陶瓷轴承相同类型的植入物。评估术前、术后第 1 天和第 2 天以及出院日的血红蛋白水平。采用 Harris 髋关节评分和西安大略和麦克马斯特大学关节炎指数评估临床和功能结果。评估两组患者的住院 LOS 和早期及晚期并发症发生率。术后行骨盆前后位 X 线检查评估植入物的正确定位。
TSPS 组较对照组具有更好的早期临床结果( = 0.0155)、更少的失血量( < 0.0001)和更短的住院 LOS( < 0.0001)。两组均未发生重大不良事件,所有患者均获得满意的植入物定位。
TSPS 入路是一种可靠的微创 THR 方法,它可以使组件准确定位,并提供更好的术后早期功能结果、更快的恢复、显著减少失血量和更短的住院时间,优于标准后入路。然而,需要进一步的研究来证实 TSPS 入路在更大队列和更长随访期的有前景的结果和成本效益。